Product Details
Product Details
Product Specification
Synonym | CTLA8; CTLA8cytotoxic T-lymphocyte-associated serine esterase 8; Cytotoxic T-lymphocyte-associated antigen 8; Cytotoxic T-Lymphocyte-Associated Protein 8; IL17; IL-17; IL-17A; IL-17A/F Heterodimer; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8); interleukin 17A; interleukin-17A |
Description |
Testing Principle:
Detection type:Double sandwich enzyme immunoassay Form: pre-coated 96-well plate Sample type: Cell culture supernatant, Serum, Plasma Sample quantity:100 μl Kit composition:pre-coated 96-well plate,Standards,IL-12P70 Detection Antibody, Standard Diluent, Detection Buffer, Signal Enhancer, Signal Enhancer Diluent, TMB Color Substent, Washing Solution, Terminating Solution, SA-HRP, Sealing Plate Mask and Instructions Sensitivity:0.20 pg/mL Detection range:0.78-50 pg/mL Recovery rate:80-95% Storage:2-8℃ The standard curve: Background: Interleukin 17A(IL-17 or IL-17A), a representative member of the IL-17 family of cytokines, is produced by helper T lymphocytes and can be induced by IL-23. IL-17 cytokines can effectively recruit monocytes and neutrophils to inflammatory sites by increasing the production of chemokines in tissues, thereby delaying the occurrence of inflammation. When an extracellular pathogen invades the immune system, IL-17, a pro-inflammatory cytokine, responds by destroying the pathogen's cells. IL-17 exerts synergistic effects with tumor necrosis factor and IL-1. The IL-17 family is associated with a number of immune/autoimmune-related diseases, such as rheumatoid arthritis, asthma, lupus, allograft rejection, anti-tumor immunity, psoriasis, multiple sclerosis. |
